Samsung Biologics recognized as a global leader in water security

Core Insights - Samsung Biologics has achieved an 'A' rating in Water Security from the Carbon Disclosure Project (CDP), marking a significant improvement from the previous year [1][2] - The CDP 'A List' recognizes companies that demonstrate exceptional leadership in environmental stewardship, with only about 2% of participating companies receiving this distinction [2][3] Company Achievements - Samsung Biologics has been participating in CDP assessments for two years and has improved its rating by one level, reflecting its commitment to sustainability [2] - The company was acknowledged for setting concrete goals in natural capital strategies, water pollution management, and water reuse rates, along with high accuracy in reporting water-related data [4] Strategic Goals - The CEO of Samsung Biologics emphasized the company's ongoing commitment to align with global ESG strategies and aims for carbon neutrality while enhancing water resource management [4] - Samsung Biologics is a champion of the Supply Chains Working Group within the Sustainable Markets Initiative (SMI) Health Systems Task Force, reinforcing its role as a sustainable CDMO partner [4] Operational Capacity - Samsung Biologics operates with a biomanufacturing capacity of 784,000 liters across five plants, utilizing advanced technologies for various biopharmaceutical modalities [5] - The company implements the ExellenSâ"¢ framework to ensure manufacturing continuity and operational excellence across its facilities [6] Commitment to Sustainability - Samsung Biologics is focused on transitioning to renewable energy by 2050 and aims to manage natural capital while reducing climate impact throughout its value chain [4][7] - The company is dedicated to delivering safe, high-quality products on time and in full, while making sustainable business decisions for societal and global health benefits [7]